C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132508 Mammalian chemokine reagents
11/07/2006	US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006	US7132407 N'-neu-IL-2 fusion gene controlled by a cytomegalo virus promoter
11/07/2006	US7132406 Stimulation of cellular regeneration and differentiation in the inner ear
11/07/2006	US7132405 Targeting vector to the urokinase plasminogen activator receptor
11/07/2006	US7132404 Liposome, a ligand and a polymeric scaffold; ligand can bind to a cell surface receptor or molecule expressed by the target cell
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006	US7132292 Anther-specific promoter from the rice TUB8 gene and uses thereof
11/07/2006	US7132291 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/07/2006	US7132290 Recombinase-based system for combustion of adenovirus vectors
11/07/2006	US7132289 Method for introducing foreign matters into living cells
11/07/2006	US7132285 Extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells to patient; T-cell- mediated and inflammatory disorders
11/07/2006	US7132284 Adenovirus packaging cell lines
11/07/2006	US7132282 Genetic modification of C57 mice
11/07/2006	US7132280 Genetically engineered cell for use in the generation of vaccines against bacterial and viral infections
11/07/2006	US7132278 Mixture containing preferential polypeptide for use in treatment of tumors
11/07/2006	US7132277 nucleic acid molecule comprising modified adenovirus packaging signal sequences having a consensus sequence, flanked by recombinase recognition sequence, used for drug delivery and genetic vaccines
11/07/2006	US7132276 Human p51 genes and gene products thereof
11/07/2006	US7132273 polynucleotides codes, cells transformed with genetic vectors and gene expression of heterologous polypeptides or proteins on the surfaces of cells; biochemical immobilization; biocatalysts; altering target protein characteristics such as binding affinity and stability by library screening
11/07/2006	US7132272 Nucleotide sequence encoding corynebacterium glutamicum leucine response regulatory protein
11/07/2006	US7132271 Methods for enhancing the production of viral vaccines in cell culture
11/07/2006	US7132270 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
11/07/2006	US7132268 transfection of genetic vectors containing DNA that code proteins into prokaryotic host cells, then culturing, allowing the cells to produce and accumulate isoprenoids, and recovering the isoprenoids consisting of ubiquinone, vitamin K2 and carotenoid
11/07/2006	US7132266 Method and kit for analyzing target nucleic acid fragment
11/07/2006	US7132265 Circular site-directed mutagenesis
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132263 Expression vectors comprising nucleotide sequences coding polypeptides which confer freeze resistance and tolerance; generation and propagation of cold tolerant crop plants
11/07/2006	US7132262 administering codon optimized polynucleotides that code human papillomavirus polypeptides comprising early proteins or fragments to cells of mammals; gene therapy; DNA vaccines
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	US7132260 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
11/07/2006	US7132259 nucleic acids encoding neurotoxin polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; for biosynthesis of botulinum neurotoxins in host cells
11/07/2006	US7132258 transcriptional co-activator RAC3 protein that interacts with and activates an activation function-2 (AF-2) domain-containing steroid/nuclear receptor; useful for modulating the effects of steroid/nuclear hormones and their receptors
11/07/2006	US7132257 Production or aromatic carotenoids in gram negative bacteria
11/07/2006	US7132253 lowered activity for N-ethylglycine; reagent for measuring creatinine or creatine
11/07/2006	US7132250 Isopentenyl diphosphate biosynthetic enzymes
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132243 Propagation lymphocytes; obtain cells, incubate in nutrient broth, propagate recover cells
11/07/2006	US7132242 Method and device for targeted delivery of materials to selected single cells
11/07/2006	US7132241 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4
11/07/2006	US7132240 Obtaining chromosomal DNA from plants for preparing expression vectors comprising artificial chromosomes
11/07/2006	US7132238 Method of determining a chemotherapeutic regimen based on ERCC1 expression
11/07/2006	US7132121 Inhibition of viral infection using antigen-binding proteins
11/07/2006	US7132106 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
11/07/2006	US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006	US7132082 Especially useful with sample tubes having penetrable caps.
11/07/2006	CA2277824C Dosage composition for nasal delivery and method of use of the same
11/07/2006	CA2226436C Generation of immune responses to prostate-specific antigen (psa)
11/07/2006	CA2196780C A liposomal delivery system comprising cationic lipopolyamines and neutral lipids for delivery of biologically active agents
11/07/2006	CA2183856C Tcf mutant
11/07/2006	CA2128511C Monomeric and dimeric antibody-fragment fusion proteins
11/07/2006	CA2097523C Alkaline proteases from bacillus pumilus
11/07/2006	CA2092661C Modification of vegetable oils using desaturase
11/07/2006	CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
11/07/2006	CA2039517C Dna probe signal amplification
11/02/2006	WO2006116756A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns
11/02/2006	WO2006116682A2 Polypeptides having endoglucanase activity and polynucleotides encoding same
11/02/2006	WO2006116657A2 Single-chain antibody with cleavable linker
11/02/2006	WO2006116458A2 Modified oligoribonucleotide analogs with enhances immunostimulatory activity
11/02/2006	WO2006116294A1 A single ribozyme to catalyze both trimming and trans-acting catalysis
11/02/2006	WO2006116272A1 Compositions and methods for binding agglomeration proteins
11/02/2006	WO2006116267A2 Cell-specific molecule and method for importing dna into osteoblast nuclei
11/02/2006	WO2006116202A1 Materials and methods for engineering resistance to tomato yellow leaf curl virus (tylcv) in plants
11/02/2006	WO2006116156A2 Toxin peptides with extended blood halflife
11/02/2006	WO2006116082A1 Materials and methods for respiratory disease control in canines
11/02/2006	WO2006116065A1 Methods for molecular delivery into cells using nanotube spearing
11/02/2006	WO2006115575A1 Regulatory regions from papaveraceae
11/02/2006	WO2006115297A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight
11/02/2006	WO2006115243A1 Method of producing cancer stem cell
11/02/2006	WO2006115234A1 Detection method for allergy-causing substance and screening method for allergy inhibitor
11/02/2006	WO2006115230A1 Compound having amino acid residue or peptide residue and process for producing the same
11/02/2006	WO2006115181A1 Method of modifying plant characters
11/02/2006	WO2006115080A1 Growth promoting agent for pluripotent stem cell
11/02/2006	WO2006115059A1 Biological information processing unit and method, program and recording medium
11/02/2006	WO2006115047A1 Gene whose expression changes in conjunction with diabetic conditions and utilization thereof
11/02/2006	WO2006115026A1 Humanin receptor or humanin-like polypeptide receptor
11/02/2006	WO2006114995A1 Method of detecting hybridization by using intercalator
11/02/2006	WO2006114834A1 Method of constructing vector for introducing point-specific functional group
11/02/2006	WO2006114700A2 Method of producing human igg antibodies with enhanced effector functions
11/02/2006	WO2006114647A1 Ion chann
11/02/2006	WO2006114616A1 Engineered peroxidases with veratryl alcohol oxidase activity
11/02/2006	WO2006114434A1 Use of elongator genes to enhance vigour and stress tolerance in eukaryotic cells
11/02/2006	WO2006114307A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	WO2006114094A1 Arabinofuranosidases
11/02/2006	WO2006113959A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006	WO2006113957A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006	WO2006096973A8 Compositions and method for storage of nucleic acid from bodily fluids
11/02/2006	WO2006095156B1 Vectors comprising novel regulatory elements
11/02/2006	WO2006089152A3 Use of methyltransferase inhibitors to enhance transgene expression
11/02/2006	WO2006087756A3 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
11/02/2006	WO2006087752A3 Cationic lipids for the transfection of nucleic acids
11/02/2006	WO2006084749A3 Rcs 02, a novel gene involved in the biosynthesis of vitamin c
11/02/2006	WO2006084712A3 Novel gene rcs 27
11/02/2006	WO2006084711A3 Novel gene sts 22
11/02/2006	WO2006084695A3 Tetracycline-controlled insertion element for systematic mutagenesis
11/02/2006	WO2006084643A3 Novel gene vcs 07
11/02/2006	WO2006078645A3 Heterologous polypeptide expression using low multiplicity of infection of viruses
11/02/2006	WO2006076902A3 Recombinant expression of proteins in a disulfide-bridged, two-chain form

1 ... 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 ... 4023